Italia - Kiitaliano - Ministero della Salute

santiveri sa -

Italia - Kiitaliano - Ministero della Salute

s.i.r.p.e.a. spa -

Italia - Kiitaliano - Ministero della Salute

s.i.r.p.e.a. spa -

Italia - Kiitaliano - Ministero della Salute

farmaderbe srl -

Italia - Kiitaliano - Ministero della Salute

s.i.r.p.e.a. spa -

Italia - Kiitaliano - Ministero della Salute

s.i.r.p.e.a. spa -

Italia - Kiitaliano - Ministero della Salute

s.i.r.p.e.a. spa -

Italia - Kiitaliano - Ministero della Salute

s.i.r.p.e.a. spa -

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - infezioni da hiv - antivirali per uso sistemico - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 e 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 e 5.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

viiv healthcare bv - dolutegravir - infezioni da hiv - antivirali per uso sistemico - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.